Silicon Laboratories, Inc.

As of June 30, 2026, Silicon Laboratories Inc. carries a market capitalization of 6.41B, placing it among publicly traded companies globally. Its enterprise value stands at 6.06B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Silicon Laboratories Inc.'s next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, Silicon Laboratories Inc. has 33.37M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 8.45, and the price-to-book ratio stands at 6.69.

These figures are as of June 30, 2026. The EV/Sales ratio of 8.09 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 6.06B versus a market cap of 6.41B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Silicon Laboratories Inc. maintains a current ratio of 5.41, meaning it holds 5.4x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Silicon Laboratories Inc. posted a negative return on equity (ROE) of -3.63, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.16, reflecting losses generated across the asset base. The company generates approximately 390,240.41 in revenue per employee across its workforce of 1,919.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.30 indicates how many times Silicon Laboratories Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Silicon Laboratories Inc. recorded 6.07M in income tax expense. The company reported a pretax loss of -28.16M and -34.23M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Silicon Laboratories Inc.'s stock has gained approximately 528.57% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Silicon Laboratories Inc. generated 749.16M in revenue and converted that into -34.23M in net income, yielding earnings per share of -1.04. EBITDA reached -8.73M, while operating income came in at -37.94M.

These figures are as of June 30, 2026. Total book value stands at 958.28M, with working capital of 478.86M providing operational flexibility.

Silicon Laboratories Inc. produced 28.97M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -33.72M in capital expenditures, free cash flow totaled -4.75M - equivalent to -0.14 per share.

Over the twelve months ended June 30, 2026, Silicon Laboratories Inc. posted a gross margin of 60.61, reflecting its pricing power and cost economics. The operating margin of -5.06 and net profit margin of -4.57 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -0.08: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 0.20, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Silicon Laboratories Inc. shareholders.

As of June 30, 2026, Silicon Laboratories Inc. has an Altman Z-Score of 30.83, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.